LONDON
TechNavio has announced the publication of a new market research report on the Global Preventable Vaccines Market, which is expected to grow at a CAGR of 10.16 percent from 2014-2019.
About the Report
According to the latest report by TechNavio, the inclusion of vaccinations in the national immunization programs of many countries will increase the accessibility of vaccines to low-income families. Various governments are conducting routine immunization schedules to ensure that vaccines are available to both adults and children.
“The Government of Australia has incorporated pediatric and adult vaccinations in their programs, and the UK government has started a childhood immunization schedule with quick guidelines for parents,” says Faisal Ghaus, Vice President of TechNavio.
The latest report by TechNavio draws attention towards increasing strategic alliances that are aimed at enhancing the product portfolio of parent companies. Large pharmaceutical companies are focused on consolidating their position in the market and increasing their respective market shares.
Additionally, vaccine manufacturers are shifting their bases to developing countries in order to capitalize on the favorable business conditions in these countries.
“Global players are targeting countries like India and China as vaccine development hubs because of the availability of skilled manpower, excellent manufacturing capabilities and low-manufacturing costs,” says Ghaus.
Key Information Covered in the Report:
- Market segmentation, size and forecast through 2019
- Market Growth Drivers:
- Inclusion in NIPs
- For a full detailed list, view our report.
- Market Challenges:
- Inadequate Vaccine Coverage
- For a full detailed list, view our report.
- Market Trends:
- Increase in Strategic Alliances
- For a full detailed list, view our report.
- Key Vendors:
- GlaxoSmithKline plc
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Other Prominent Vendors:
- Abbott
- Bavarian Nordic
- Baxter
- bioCSL
TechNavio currently has more than 3000 market research reports on a huge range of topics, including 300+ reports on the vaccines market:
If you are interested in more information, please contact our media team at media@technavio.com.
CONTACT
TechNavio Research
Jes Ellacott
US: +1-630-333-9501
UK:
+44 208 123 1770
Media & Marketing Executive
www.technavio.com
media@technavio.com
